Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Abramowitz

Vascular Surgery Washington, DC Medical Doctor

NPI 1821222001 CMS profile 355571

106 Irving St Nw, Physician Office Building, Suite 3150 North Tower, Washington, DC 20010

Open in the dashboard

General payments

$722,498

646 records reported · program years 2019–2025

Research payments

$5,400

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$249,989 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Steven Abramowitz of Washington, DC is reported in the CMS Open Payments database as having received $722,498 across 646 general payments and $5,400 in research payments paid to them. Separately, studies naming them as principal investigator received $249,989 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $173,468 132
2024 General $124,678 128
2024 Research $2,000 2
2023 General $163,677 154
2023 Research $3,400 1
2022 General $131,956 118
2021 General $70,571 51
2020 General $41,379 31
2019 General $16,769 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Abramowitz
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Steven Abramowitz were reported at $173,468. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Steven Abramowitz Vascular Surgery median Middle half National median
2019 $16,769 $796 $226–$2,363 $163
2020 $41,379 $348 $118–$1,110 $114
2021 $70,571 $471 $158–$1,421 $132
2022 $131,956 $725 $222–$2,183 $149
2023 $163,677 $836 $257–$2,440 $160
2024 $124,678 $909 $252–$2,619 $164
2025 $173,468 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $372,076 206 payments
  2. Stryker Corporation $101,196 47 payments
  3. Boston Scientific Corporation $94,679 119 payments
  4. W. L. Gore & Associates, Inc. $58,893 89 payments
  5. Philips Electronics North America Corporation $51,166 59 payments
  6. Medtronic, Inc. $11,780 34 payments
  7. Argon Medical Devices, Inc. $6,706 14 payments
  8. Cook Incorporated $6,548 4 payments
  9. Cardiovascular Systems Inc. $5,446 9 payments
  10. Bard Peripheral Vascular, Inc. $4,745 15 payments
  11. Other $9,264 50 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $386,150 146 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $201,915 71 payments
  3. Travel and Lodging $93,402 120 payments
  4. Food and Beverage $23,315 291 payments
  5. Education $8,344 8 payments
  6. Honoraria $7,735 8 payments
  7. Grant $1,238 1 payment
  8. Compensation for serving as faculty or as a speaker for a medical education program $400 1 payment
Products named General payments · program years 2019–2025
  1. CT THROMBECTOMY SYSTEM KIT $489,629 222 payments
  2. FLOWTRIEVER CATHETER, S $379,503 232 payments
  3. ClotTriever $34,502 14 payments
  4. FlowTriever $34,502 14 payments
  5. GORE VIABAHN Endoprosthesis $27,803 11 payments
  6. GORE PROPATEN Vascular Graft $25,520 4 payments
  7. General - Therapies $25,507 24 payments
  8. GORE VIABAHN VBX Balloon Expandable Endo $17,865 26 payments
  9. (9520) IGT Devices Undivided $17,542 21 payments
  10. Product in Development $17,030 17 payments
  11. Other $191,319 296 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $3,400 1 payment
  2. Mercator MedSystems, Inc. $2,000 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

32

Median for Vascular Surgery: 122

Drug cost

$448

Median for Vascular Surgery: $14,135

Branded share of claims

100%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 32 $448

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 117 billing codes

Paid by Medicare

$236,337

Medicare's payments for the services billed

Medicare patients

1,807

Average age 74

Services billed

3,237

999 women, 808 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 58%
Ischemic heart disease 55%
Arthritis 55%
Chronic kidney disease 52%
Heart failure 45%
Atrial fibrillation 32%
Depression 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

649 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record